Ubs Asset Management Americas Inc Olema Pharmaceuticals, Inc. Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 75,974 shares of OLMA stock, worth $463,441. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75,974
Previous 83,590
9.11%
Holding current value
$463,441
Previous $904,000
0.33%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding OLMA
# of Institutions
136Shares Held
58.7MCall Options Held
141KPut Options Held
23.1K-
Bvf Inc San Francisco, CA9.14MShares$55.7 Million3.47% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5.5MShares$33.6 Million2.37% of portfolio
-
Deep Track Capital, LP Greenwich, CT4MShares$24.4 Million1.76% of portfolio
-
Black Rock Inc. New York, NY4MShares$24.4 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.69MShares$22.5 Million0.12% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $247M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...